Prior studies demonstrated that PI3K/Akt signaling is important in thyroid hormone receptor βPV/PV knock-in (PV) mice that develop metastatic thyroid cancer that most closely resembles FTC. This evidence concerns the gene AKT1 and thyroid cancer, nonmedullary, 2.